A national strategy for UK musculoskeletal clinical research: Arthritis Research UK Clinical Studies initiative

Rheumatology

Volumn 50, Issue 4, 2011, Pages 640-642

  Silman, Alan J ^a   Rudkin, Sarah ^a  

^a Arthritis Research UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR;

ARTHRITIS; EDITORIAL; FEASIBILITY STUDY; FUNDING; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; UNITED KINGDOM; UVEITIS;

ARTHRITIS; BIOMEDICAL RESEARCH; FEASIBILITY STUDIES; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; MUSCULOSKELETAL DISEASES;

EID: 79952796635     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq198     Document Type: Editorial

References (5)

1. Silman AJ. A new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (ARC) Clinical Studies Groups initiative. Rheumatology 2008;47: 777-9.
2. NIHR Health Technology Assessment programme. Call for research proposals into juvenile idiopathic arthritis http://www.hta.ac.uk/news/newsitem030409.shtml.
3. UKCRC Clinical Trials Units Oversight Group. Review of current core capacity of UKCRC registered clinical trials units and future resource requirements for the development and delivery of academic-led, late phase, randomised controlled trials across the UK, 2008.
4. Department of Health. Attributing revenue costs of externally funded non-commercial research in the NHS (ARCO), 2005.
5. Department of Health. HSG (97)32: responsibilities for meeting patient care costs associated with research and development in the NHS, 1997.